657 related articles for article (PubMed ID: 10568615)
1. Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.
Fine PE; Carneiro IA
Am J Epidemiol; 1999 Nov; 150(10):1001-21. PubMed ID: 10568615
[TBL] [Abstract][Full Text] [Related]
2. Eradicating polio: how the world's pediatricians can help stop this crippling illness forever.
Orenstein WA;
Pediatrics; 2015 Jan; 135(1):196-202. PubMed ID: 25548328
[TBL] [Abstract][Full Text] [Related]
3. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
4. Assessing the stability of polio eradication after the withdrawal of oral polio vaccine.
Famulare M; Selinger C; McCarthy KA; Eckhoff PA; Chabot-Couture G
PLoS Biol; 2018 Apr; 16(4):e2002468. PubMed ID: 29702638
[TBL] [Abstract][Full Text] [Related]
5. Strengths and weaknesses of current polio vaccines--a view from industry.
André FE
Dev Biol (Basel); 2001; 105():61-6. PubMed ID: 11763338
[TBL] [Abstract][Full Text] [Related]
6. Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.
Friedrich F
Acta Virol; 2000 Apr; 44(2):109-17. PubMed ID: 10989702
[TBL] [Abstract][Full Text] [Related]
7. Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization.
Sarnquist C; Holubar M; García-García L; Ferreyra-Reyes L; Delgado-Sánchez G; Cruz-Hervert LP; Montero-Campos R; Altamirano J; Purington N; Boyle S; Modlin J; Ferreira-Guerrero E; Canizales-Quintero S; Díaz Ortega JL; Desai M; Maldonado YA
Clin Infect Dis; 2018 Oct; 67(suppl_1):S115-S120. PubMed ID: 30376084
[TBL] [Abstract][Full Text] [Related]
8. Poliovirus vaccines. Progress toward global poliomyelitis eradication and changing routine immunization recommendations in the United States.
Sutter RW; Prevots DR; Cochi SL
Pediatr Clin North Am; 2000 Apr; 47(2):287-308. PubMed ID: 10761505
[TBL] [Abstract][Full Text] [Related]
9. [Polio vaccines, eradication and posterradication].
Salmerón García F; Portela Moreira A; Soler Soneira M; López Hernández S; Chamorro Somoza Díaz-Sarmiento M; Pérez González I; Rubio Gómez MI; Pérez González A; Sagredo Rodríguez A; Ruiz Antúnez S; Timón Jiménez M; Frutos Cabanillas G
Rev Esp Salud Publica; 2013; 87(5):497-505. PubMed ID: 24322286
[TBL] [Abstract][Full Text] [Related]
10. Expected Implications of Globally Coordinated Cessation of Serotype 3 Oral Poliovirus Vaccine (OPV) Before Serotype 1 OPV.
Kalkowska DA; Thompson KM
Risk Anal; 2021 Feb; 41(2):312-319. PubMed ID: 32936466
[TBL] [Abstract][Full Text] [Related]
11. Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.
Duintjer Tebbens RJ; Pallansch MA; Wassilak SG; Cochi SL; Thompson KM
BMC Infect Dis; 2016 Mar; 16():137. PubMed ID: 27009272
[TBL] [Abstract][Full Text] [Related]
12. Cessation of Trivalent Oral Poliovirus Vaccine and Introduction of Inactivated Poliovirus Vaccine - Worldwide, 2016.
Hampton LM; Farrell M; Ramirez-Gonzalez A; Menning L; Shendale S; Lewis I; Rubin J; Garon J; Harris J; Hyde T; Wassilak S; Patel M; Nandy R; Chang-Blanc D;
MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(35):934-8. PubMed ID: 27606675
[TBL] [Abstract][Full Text] [Related]
13. Eradication of poliomyelitis in the United States.
Nathanson N
Rev Infect Dis; 1982; 4(5):940-50. PubMed ID: 7146731
[TBL] [Abstract][Full Text] [Related]
14. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of inadvertent trivalent oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 Jun; 16():237. PubMed ID: 27246198
[TBL] [Abstract][Full Text] [Related]
15. Implementation of coordinated global serotype 2 oral poliovirus vaccine cessation: risks of potential non-synchronous cessation.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2016 May; 16():231. PubMed ID: 27230071
[TBL] [Abstract][Full Text] [Related]
16. Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use.
Duintjer Tebbens RJ; Hampton LM; Thompson KM
BMC Infect Dis; 2018 Apr; 18(1):165. PubMed ID: 29631539
[TBL] [Abstract][Full Text] [Related]
17. The final stages of the global eradication of poliomyelitis.
Grassly NC
Philos Trans R Soc Lond B Biol Sci; 2013 Aug; 368(1623):20120140. PubMed ID: 23798688
[TBL] [Abstract][Full Text] [Related]
18. Poliomyelitis: eradication in sight.
Melnick JL
Epidemiol Infect; 1992 Feb; 108(1):1-18. PubMed ID: 1547830
[TBL] [Abstract][Full Text] [Related]
19. Polio endgame: the global introduction of inactivated polio vaccine.
Patel M; Zipursky S; Orenstein W; Garon J; Zaffran M
Expert Rev Vaccines; 2015 May; 14(5):749-62. PubMed ID: 25597843
[TBL] [Abstract][Full Text] [Related]
20. Possible global strategies for stopping polio vaccination and how they could be harmonized.
Cochi SL; Sutter RW; Aylward RB
Dev Biol (Basel); 2001; 105():153-8; discussion 159. PubMed ID: 11763323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
